SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $136,239,482 |
| Positions | 35 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $14,362,491 | 42,900 |
| WHITEHAWK THERAPEUTICS INC | WHWK | COM | $9,920,266 | 2,165,997 |
| ERASCA INC | ERAS | COM | $8,335,600 | 455,000 |
| TREVI THERAPEUTICS INC | TRVI | COM | $7,721,100 | 414,000 |
| SUTRO BIOPHARMA INC | STRO | COM SHS | $7,522,290 | 226,575 |
| TANGO THERAPEUTICS INC | TNGX | COM | $7,198,053 | 230,264 |
| MBX BIOSCIENCES INC | MBX | COM | $6,708,125 | 121,524 |
| PROTAGONIST THERAPEUTICS INC | PTGX | COM | $6,496,740 | 53,000 |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $5,403,790 | 133,000 |
| TANDEM DIABETES CARE INC | TNDM | COM NEW | $4,542,090 | 301,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.